Optimization of cannabinoids for development as FDA-approved migraine therapeutics
Ended Project Grant Awarded Last action
- Award ID
- R41DA051309
- Recipient
-
Schedule 1 Therapeutics Inc. UEI TV68WM7PHYW3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,510
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Iowa, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$8,955 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $308,465 |
Quick answers
Who received award R41DA051309?
R41DA051309 was awarded to Schedule 1 Therapeutics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2020.
How much is award R41DA051309 worth?
$299,510 has been obligated on R41DA051309.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award